Category: Include on Menu
-
National Vision tops Q4 expectations, shares dip on cautious outlook
National Vision Holdings, Inc. (NASDAQ:EYE) reported fourth-quarter results on Wednesday that came in above analyst forecasts. Despite the stronger-than-expected performance, the company’s shares fell 1.09% in premarket trading as investors evaluated the retailer’s fiscal 2026 guidance relative to market expectations. The optical retailer reported adjusted earnings per share of $0.15 for the quarter, surpassing the…
-
CrowdStrike tops Q4 expectations, provides steady outlook for fiscal 2027
CrowdStrike (NASDAQ:CRWD) reported fourth-quarter results that exceeded Wall Street forecasts and issued guidance for fiscal 2027 that was broadly in line with market expectations, as investors continue to assess the impact of artificial intelligence on the software sector. Shares of the cybersecurity company rose 1.4% in U.S. premarket trading on Wednesday. The stock has declined…
-
Wix.com matches Q4 revenue expectations, forecasts mid-teens growth for 2026
Wix.com (NASDAQ:WIX) reported fourth-quarter revenue of $524.3 million, up 14% from a year earlier and broadly in line with analysts’ average estimate of $527.9 million, according to Bloomberg consensus data. The company posted non-GAAP operating income of $81.2 million for the quarter, exceeding the $77.1 million analysts had expected. Adjusted gross profit reached $358.8 million,…
-
GitLab shares slide after disappointing earnings guidance
Shares of GitLab (NASDAQ:GTLB) dropped 8.8% to $24.35 in premarket trading on Wednesday after the software development platform issued a fiscal 2027 earnings outlook that came in below Wall Street expectations. The company forecast adjusted earnings per share of between 76 cents and 80 cents for fiscal 2027, well under analysts’ consensus estimate of $1.05,…
-
Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute
Moderna (NASDAQ:MRNA) has reached a settlement worth up to $2.25 billion with Genevant Sciences, a subsidiary of Roivant Sciences (NASDAQ:ROIV), and Arbutus Biopharma (NASDAQ:ABUS), resolving a patent dispute tied to its COVID-19 vaccine. The agreement brings to an end multiple legal cases in the United States and internationally that alleged Moderna used lipid nanoparticle (LNP)…
-
Novo Nordisk gains after FDA issues warnings to telehealth firms over compounded GLP-1 drugs
Shares of Novo Nordisk (NYSE:NVO) climbed more than 3% on Wednesday after the U.S. Food and Drug Administration sent warning letters to 30 telehealth companies over false or misleading marketing of compounded GLP-1 medications, including versions of the company’s semaglutide and Eli Lilly’s tirzepatide. According to the FDA, the companies breached regulations by promoting compounded…
-
Latham Group shares climb after stronger-than-expected quarterly sales
Shares of Latham Group (NASDAQ:SWIM) surged 19.6% to $7.76 in premarket trading on Wednesday after the swimming pool manufacturer posted fourth-quarter results that came in ahead of analysts’ forecasts. The company reported that net sales for the quarter rose 14.5% compared with the same period a year earlier. Latham Group also highlighted particularly strong performance…
-
Oil jumps as Middle East conflict raises supply concerns; Goldman upgrades outlook
Oil prices climbed sharply on Wednesday, extending strong gains from the previous two sessions as the escalating conflict involving the United States, Israel, and Iran heightened fears of disruptions to global crude supply. At 03:40 ET (08:40 GMT), Brent crude futures for May delivery were up 3.5% at $84.25 per barrel, while U.S. West Texas…
-
Gold rebounds after sharp fall as Iran tensions revive safe-haven interest
Gold prices moved higher in Asian trading on Wednesday, recovering part of the steep losses recorded in the previous session as investors reconsidered demand for safe-haven assets amid escalating tensions between the United States and Iran and a surge in the U.S. dollar. Spot gold rose 1.2% to $5,150.63 per ounce as of 01:45 ET…
-
Bitcoin Holds Near $68K as Trump Voices Support While Iran Tensions Weigh on Crypto
Bitcoin (COIN:BTCUSD) traded largely steady on Wednesday, drawing limited support after U.S. President Donald Trump called for stronger regulatory backing for the cryptocurrency sector. However, ongoing concerns surrounding the conflict between the United States and Iran — and the potential inflationary consequences of the situation — continued to weigh on digital assets, curbing momentum after…